Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model
- PMID: 8254032
- PMCID: PMC288478
- DOI: 10.1172/JCI116897
Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model
Abstract
Rats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degradation in gastrocnemius muscle, heart, and liver, while fractional synthesis rates were similar to those in non-tumor bearing rats. This hypercatabolic pattern was associated with marked perturbations of the hormonal homeostasis and presence of tumor necrosis factor in the circulation. The daily administration of a goat anti-murine TNF IgG to tumor-bearing rats decreased protein degradation rates in skeletal muscle, heart, and liver as compared with tumor-bearing rats receiving a nonimmune goat IgG. The anti-TNF treatment was also effective in attenuating early perturbations in insulin and corticosterone homeostasis. Although these results suggest that tumor necrosis factor plays a significant role in mediating the changes in protein turnover and hormone levels elicited by tumor growth, the inability of such treatment to prevent a reduction in body weight implies that other mediators or tumor-related events were also involved.
Similar articles
-
Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals.Arch Biochem Biophys. 1993 Oct;306(1):52-8. doi: 10.1006/abbi.1993.1479. Arch Biochem Biophys. 1993. PMID: 8215420
-
Humoral mediation for cachexia in tumour-bearing rats.Br J Cancer. 1993 Jan;67(1):15-23. doi: 10.1038/bjc.1993.4. Br J Cancer. 1993. PMID: 8427775 Free PMC article.
-
Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats.J Natl Cancer Inst. 1993 Aug 18;85(16):1334-9. doi: 10.1093/jnci/85.16.1334. J Natl Cancer Inst. 1993. PMID: 8340946
-
The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting.Eur Cytokine Netw. 2000 Dec;11(4):552-9. Eur Cytokine Netw. 2000. PMID: 11125297 Review.
-
Comparative studies on protein turnover regulations in tumor cells and host tissues: development and analysis of an experimental model.Toxicol Pathol. 1986;14(4):451-6. doi: 10.1177/019262338601400411. Toxicol Pathol. 1986. PMID: 3544167 Review.
Cited by
-
Febuxostat improves outcome in a rat model of cancer cachexia.J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):174-80. doi: 10.1002/jcsm.12017. Epub 2015 Apr 21. J Cachexia Sarcopenia Muscle. 2015. PMID: 26136193 Free PMC article.
-
Leptin in anorexia and cachexia syndrome.Int J Pept. 2012;2012:287457. doi: 10.1155/2012/287457. Epub 2012 Feb 8. Int J Pept. 2012. PMID: 22518191 Free PMC article.
-
Thermoregulation as a disease tolerance defense strategy.Pathog Dis. 2016 Dec;74(9):ftw106. doi: 10.1093/femspd/ftw106. Epub 2016 Nov 3. Pathog Dis. 2016. PMID: 27815313 Free PMC article. Review.
-
Lipopolysaccharide-induced upregulation of tumor necrosis factor-alpha (TNF-alpha) in rat spinal cord.Inflammation. 2008 Oct;31(5):336-43. doi: 10.1007/s10753-008-9083-1. Inflammation. 2008. PMID: 18791857
-
Modulating Metabolism to Improve Cancer-Induced Muscle Wasting.Oxid Med Cell Longev. 2018 Jan 29;2018:7153610. doi: 10.1155/2018/7153610. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29785246 Free PMC article. Review.